Clinical trial
Combined CABG and Stem-Cell Transplantation for Heart Failure
NCT00418418 · University of Helsinki, Other · Unknown status
Key facts
| NCT number | NCT00418418 |
|---|---|
| Title | Combined CABG and Stem-Cell Transplantation for Heart Failure |
| Official title | Combined CABG and Stem-Cell Transplantation for Heart Failure |
| Lead sponsor | University of Helsinki, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Heart Failure, Myocardial Infarction, Coronary Artery Disease |
| Intervention type | Biological, Procedure |
| Interventions | Coronary bypass operation, Bone marrow aspiration (crista iliaca), Intramyocardial mesenchymal stem cell transplantation, Intramyocardial injection of autologous serum |
| Enrollment | 60 |
| Start date | Oct 1, 2006 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2010 |
| First posted | Jan 4, 2007 |
| Last update posted | Aug 19, 2008 |
| Countries | Finland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: